Here you will find answers to your questions regarding the reverse share split in Scandinavian Real Heart AB.
Since the financing model for emerging life science companies largely relies on share issues, the number of shares can often become quite large over time, resulting in a low price per share that negatively impacts trading. Daily percentage fluctuations can become significant, and the company risks being negative associated with “penny stocks.” The board’s assessment, shared by its financial advisors, is that a reverse share split would be beneficial for the company.
The actual value of an individual shareholder’s holdings is not impacted by the consolidation.
A reverse share split means that the company’s shares are reduced by combining shares, whereby the total number of shares in the company is reduced. The exchange ratio in the reverse share split proposed in Scandinavian Real Heart AB is 1:100. For everyone hundred (100) shares you hold in the company before the reverse share split, you will hold one (1) share in the company after the reverse share split.
If your shareholding is not evenly divisible by one hundred (100), your shareholding will be rounded up, which means that you will receive as many shares as required from Najar Medical and Invention AB free of charge that your holding, after the addition of the provided shares, will be evenly divisible by one hundred (100).
No, you do not need to take any action.
Provided that the general meeting resolves on the proposed reverse share split, the board of directors is authorised to determine the record date for the reverse share split. More information about the record date will be communicated through a press release on the company’s website, www.realheart.se, once the board of directors has determined the record date for the reverse share split.
To participate in the general meeting, you must be entered in the share register no later than Monday, 28 October 2024 and have notified the company no later than Wednesday, 30 October 2024. Registration for the meeting shall be made by post to Setterwalls Advokatbyrå AB, attn: Anna af Petersens, P.O. Box 1050, 101 39 Stockholm or by e-mail to anna.afpetersens@setterwalls.se. The notification shall state full name, personal identification number/company registration number, shareholding, address, daytime telephone number and, if applicable, information about proxies or assistants (maximum two).
After the reverse split, each one hundred (100) warrants held will entitle the holder to subscribe for one (1) new share in the company at a subscription price corresponding to one hundred (100) times the subscription price determined prior to the reverse split.